Detailed text transcripts for TV channel - CNN - 20161017:05:45:00
And is the most prescribed immunotherapy for these patients. opdivo significantly increased the chance of living longer versus chemotherapy. no biomarker testing is required with opdivo, though physicians may choose to do so. opdivo works with your immune system. opdivo can cause your immune system to attack normal organs and tissues in your body and affect how they work. this may happen any time during or after treatment has ended, and may become serious and lead to death. see your doctor right...
Source: news source